CLINICAL_TRIALS
trial_result
· 2011-10-04
Clinical Trial Update: Safety and Pharmacokinetics Study of XOMA 052 in Subjects With Type 2 Diabetes Mellitus [Phase 1, Phase 2]
Summary
Completed safety and pharmacokinetics study of XOMA 052 in subjects with type 2 diabetes mellitus (Phase 1/2).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: XOMA (US) LLC | Conditions: Type 2 Diabetes | Phase 1, Phase 2 | Status: COMPLETED